Bristol Myers plays it safe with first Zeposia TV ad for ulcerative colitisnews2022-01-14T12:55:53+00:00January 14th, 2022|Fierce Pharma|
Fierce Pharma Asia—Takeda, Denali’s Alzheimer’s hiccup; Daiichi Sankyo’s R&D reorg; J&J, Legend’s CAR-T supply prepnews2022-01-14T09:37:47+00:00January 14th, 2022|Fierce Pharma|
JPM 2022: Bluebird bio hopes for clear skies ahead as it gears up for trio of gene therapy launchesnews2022-01-13T16:50:06+00:00January 13th, 2022|Fierce Pharma|
Biogen CEO Vounatsos summons support to fight Aduhelm’s paralyzing coverage decisionnews2022-01-13T15:29:40+00:00January 13th, 2022|Fierce Pharma|
CDMO startup INCOG Bio nears completion of injectables plant in Indiananews2022-01-13T15:15:42+00:00January 13th, 2022|Fierce Pharma|
Drug repackager Loxha recalls OTC laxative contaminated with microbesnews2022-01-13T14:02:57+00:00January 13th, 2022|Fierce Pharma|
JPM 2022: Novartis rewrites the drug launch playbook with Leqvio, and it doesn’t plan to stop there, exec saysnews2022-01-13T13:39:54+00:00January 13th, 2022|Fierce Pharma|
Genentech, American Cancer Society flash back to the ’70s in PSA to destigmatize lung cancer, encourage screeningsnews2022-01-12T20:37:24+00:00January 12th, 2022|Fierce Pharma|
AstraZeneca sells another half-million doses of its COVID-19 antibody combo to the USnews2022-01-12T19:39:27+00:00January 12th, 2022|Fierce Pharma|
Performance Cell picked up by private equity firm, rebrands as Cellipont Bioservicesnews2022-01-12T13:36:56+00:00January 12th, 2022|Fierce Pharma|
